Inhibition of ceramide synthesis improves the outcome of ischemia/reperfusion injury in cardiomyocytes derived from human induced pluripotent stem cell
P Haxhikadrija(Jena University Hospital), Mohamed M. Bekhite(Jena University Hospital), Claudia Backsch(Jena University Hospital), Elisabeth Klein(Inova Health System), Markus H. Gräler(Jena University Hospital), Sascha Hübner(Jena University Hospital), Jasmine Wu(Jena University Hospital), Tina Müller(Scripps Research Institute), Anja Weise, P. Christian Schulze(Temple College), Katja Grün(Jena University Hospital), Tom Kretzschmar(Jena University Hospital)
Cited by 6
Related Papers
2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2021|13.1k
2023 Focused Update of the 2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure
|European Heart Journal|2023|2.2k
The SGLT2 inhibitor empagliflozin in patients hospitalized for acute heart failure: a multinational randomized trial
|Nature Medicine|2022|889